Market Alert: Strong Nuclear Tensions in South Asia Assessing the Fallout on Global Equity Markets
AgResearch subsidiary Grasslanz Technology has been awarded the 2025 Science New Zealand Supreme Award for its groundbreaking work in plant technology. Announced at the Beehive on March 12, the award recognizes the company's development of Epichloë, a fungal symbiont that enhances ryegrass resilience against insects and diseases. This innovation is projected to contribute $3.6 billion to New Zealand’s economy over its 20-year patent life. Science NZ praised Grasslanz Technology for translating scientific advancements into practical agricultural solutions, benefiting farmers and growers nationwide.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Apr 28, 2025
Apr 28, 2025
Apr 24, 2025
Apr 24, 2025
Apr 23, 2025
Apr 14, 2025
Apr 11, 2025
Apr 11, 2025
Apr 10, 2025
Apr 10, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is based in Australia. The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
